From tragedy, a potential pediatric cancer treatment

Cold Spring Harbor Laboratory Professor Adrian Krainer is best known for his groundbreaking research on antisense oligonucleotides (ASOs)—m...

April 13, 2023 | Thursday | News
Karmanos Cancer Institute invests in software to identify and manage patients at high risk of developing breast cancer

The Barbara Ann Karmanos Cancer Institute, a leading breast cancer prevention and care provider, has adopted Volpara® Risk Pathways™, a market-le...

April 12, 2023 | Wednesday | News
Nuvectis Pharma begins Phase 1b study for NXP800 in ARID1a-Mutated Ovarian Cancer

Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative pre...

April 11, 2023 | Tuesday | News
GC Genome shows Liquid Biopsy Technology can predict response to Radiation Therapy in Solid Tumors

The research was in collaboration with the Samsung Medical Center, Sungkyunkwan University School of Medicine. This study adds to the previous studies of p...

April 10, 2023 | Monday | News
OBI Pharma presents OBI-999 combo and Globo H-targeted CAR T-cell immunotherapy posters at AACR 2023

OBI Pharma, Inc. (TPEx: 4174) today announced preclinical data demonstrating significant synergistic effects of OBI-999 and pembrolizumab (anti-PD1 mAb) in...

April 10, 2023 | Monday | News
Researchers Identify Novel Immunotherapeutic Compound Targeting Key Cancer Pathway

Under normal circumstances, interactions between PD-1 and its ligand PD-L1 can halt or limit the immune system’s response to human cells and suppress...

April 09, 2023 | Sunday | News
Asia Pacific Cancer Biomarkers Market Analysis

Cancer is one of the leading causes of death across Asian countries. According to a report published by Janssen Asia Pacific, in 2017, overall, there wer...

April 07, 2023 | Friday | News
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial of GD2-SADA

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the de...

April 06, 2023 | Thursday | News
Deka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of DK210 (EGFR)

he Phase 1, first-in-human, multicenter clinical study seeks to characterize the safety, potential efficacy and evaluate possible biomarkers of response to...

April 06, 2023 | Thursday | News
Accord BioPharma's Biosimilar Trastuzumab HLX02 BLA Accepted by US FDA

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, ...

April 06, 2023 | Thursday | News
Everest Medicines Announces New Drug Application Acceptance by Singapore HSA

Nefecon NDA is currently under Priority Review in China and expected to receive approval in 2H 2023- Everest Medicines (HKEX 1952.HK, "...

April 06, 2023 | Thursday | News
Mercy BioAnalytics Raises $41M to Advance Mercy Halo Liquid Biopsy for Cancer Detection

The oversubscribed financing was led by Novalis LifeSciences, with participation from Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Canc...

April 04, 2023 | Tuesday | News
FDA Grants Accelerated Approval for PADCEV® with KEYTRUDA® for Urothelial Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Seagen Inc. (Nasdaq: SGEN) announced the U.S. Food and Drug Administrati...

April 04, 2023 | Tuesday | News
PHC Corp. and NovaScan collaborate to explore non-melanoma skin cancer detection device

PHC is a subsidiary of PHC Group*1, a global healthcare company that develops, manufactures, sells, and services solutions across the business domains of d...

April 04, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close